Ranbaxy Laboratories Limited announced the day-1 launch of its first independently developed generic product, Amlodipine tablets 2.5mg & 5mg in Japan. Amlodipine is currently the largest molecule which has gone off patent in Japan and represents the biggest generic opportunity so far in the Japanese generic market. The product has a market size of around USD 2 billion (Jan-December, 2007 - IMS - Japan), a Ranbaxy press release said.
The details can be read here.
No comments:
Post a Comment